National Health (Pharmaceutical Benefits – Early Supply) Amendment Instrument 2015 (No. 3) – specification under subsection 84AAA(2) (PB 36 of 2015) (Cth)

PB 36 of 2015

National Health (Pharmaceutical Benefits – Early Supply) Amendment Instrument 2015 (No. 3) – specification under subsection 84AAA(2)

National Health Act 1953

I, FELICITY McNEILL, First Assistant Secretary, Pharmaceutical Benefits Division, Department of Health, delegate of the Minister for Health, make this Instrument under subsection 84AAA(2) of the National Health Act 1953.

Dated 23 March 2015

FELICITY McNEILL
First Assistant Secretary
Pharmaceutical Benefits Division
Department of Health

___________________________________________________________________________

Amendment determination – Pharmaceutical Benefits – Early Supply

1          Name of Instrument

(1)   This Instrument is the National Health (Pharmaceutical Benefits – Early Supply) Amendment Instrument 2015 (No. 3) – specification under subsection 84AAA(2).

(2)This Instrument may also be cited as PB 36 of 2015.

2          Commencement

This Instrument commences on 1 April 2015.

3          Amendment of PB 30 of 2009

Schedule 1 amends the National Health (Pharmaceutical Benefits – Early Supply) Instrument 2009 – specification under subsection 84AAA(2) (PB 30 of 2009).

Schedule 1        Amendments

1. Schedule 1, after entry for Mesalazine in the form Sachet containing prolonged release granules, 2 g per sachet

   insert in the columns in the order indicated:

Sachet containing prolonged release granules, 4 g per sachet Oral 30 5

1. Schedule 1, entry for Salcatonin

   omit:

Injection 50 I.U. in 1 mL ampoule Injection 30 5